SCHEMBL9820153

SCHEMBL9820153

Cc1ccc(CS(=O)(=O)Cc2ccccc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.59
CA9 Q16790 2/20 0.50
L3MBTL1 Q9Y468 2/20 0.50
FAAH O00519 1/20 0.50
PRSS1 P07477 1/20 0.50
PRSS2 P07478 1/20 0.50
ELANE P08246 1/20 0.50
PRTN3 P24158 1/20 0.50
PRSS3 P35030 1/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
CA5A P35218 1/20 0.50
BCHE P06276 1/20 0.50
ACHE P22303 1/20 0.50
CA12 O43570 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
ATM Q13315 1/20 0.50
ALDH1A1 P00352 2/20 0.49
KDM4E B2RXH2 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4400952 0.91 KMT2A (0.62) KMT2ACA9CA1CA2CYP1A2
SCHEMBL88641 0.86 CA2 (0.64) KMT2ACA9FAAHPRSS1PRSS2
SCHEMBL28332352 0.84 CA2 (0.61) KMT2ACA9FAAHPRSS1PRSS2
Hydrochloric Acid SCHEMBL11574583 0.84 CA2 (0.61) KMT2ACA9FAAHPRSS1PRSS2
SCHEMBL10289671 0.82 KMT2A (0.58) KMT2ACA9CA1CA2CYP3A4
SCHEMBL15944742 0.82 ALDH1A1 (0.61) KMT2ACA9FAAHPRSS1PRSS2
Phenylmethanesulfonamide SCHEMBL27949309 0.81 CA2 (0.79) KMT2ACA9L3MBTL1FAAHPRSS1
Alcohol SCHEMBL8778746 0.80 PRSS1 (0.52) KMT2ACA9FAAHPRSS1PRSS2
SCHEMBL776398 0.79 CA1 (0.56) KMT2ACA9FAAHPRSS1PRSS2
SCHEMBL257997 0.79 MAPT (0.64) KMT2ACA9L3MBTL1BCHEACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11806337-B2 Small molecule activators of nicotinamide phosphoribosyltransferase (NAMPT) and uses thereof Sanford Burnham Prebys Medical Discovery Institute (US) 2023-11-07 US disclosed
EP-1675930-B1 NEW MATERIALS FOR ELECTROLUMINESCENCE AND THE UTILIZATION THEREOF MERCK PATENT GMBH (DE) 2018-05-30 EP disclosed
EP-0182299-B1 A CURABLE FLUOROELASTOMER COMPOSITION Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1991-04-03 EP disclosed
US-4748208-A FLUOROPOLYMER, BIS/PHOSPHINE/IMINIUM HALIDE, POLYHYDROXY CURING AGENT ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1988-05-31 US disclosed
EP-0182299-A2 A curable fluoroelastomer composition Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1986-05-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11806337-B2 Small molecule activators of nicotinamide phosphoribosyltransferase (NAMPT) and uses thereof NAMPT, NAPRT, NNT KMT2A 828/4885CA9 4437/4885L3MBTL1 3115/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.